QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,086 signal articles · 531 in last 24h · 103,714 total before filter · latest 32m ago
531last 24h
2509last 7d
478● bullish (7d)
254● bearish (7d)
197publishers
AllMacro237Earnings1480M&A142Regulatory15Product5Analyst29
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Zeta Global (NYSE:ZETA) Surprises With Strong Q2 CY2026 But Stock Drops
StockStory20h agobearish
Zeta Global (NYSE:ZETA) Surprises With Strong Q2 CY2026 But Stock Drops

Marketing technology company Zeta Global (NYSE:ZETA) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 43.5% year on year to $442.8 million. Guidance for next quarter’s revenue was optimistic at $470.5 million at the midpoint, 2.1% above analysts’ estimates. Its GAAP profit of $0.03 per share was significantly above analysts’ consensus estimates.

Alphabet (GOOGL) Could Be 14% Undervalued On Ad Tech Lawsuit Scrutiny
Simply Wall St.20h agobearish
Alphabet (GOOGL) Could Be 14% Undervalued On Ad Tech Lawsuit Scrutiny

Alphabet (GOOGL) is back in the legal spotlight after Teads Holding Co. filed a lawsuit in New York accusing Google of exclusionary ad tech practices that restricted competition and revenue opportunities for independent advertising platforms. See our latest analysis for Alphabet. Alphabet’s share price has moved sharply in recent sessions, with a 1-day share price return of 4.88% and a 7-day share price return of 11.93% after recent earnings, AI investment updates, and renewed legal scrutiny...

SELLAS Life Sciences Group (SLS) Is Up 11.2% After Daiwa Boosts Stake And REGAL Nears Readout - Has The Bull Case Changed?
Simply Wall St.20h agobearish
SELLAS Life Sciences Group (SLS) Is Up 11.2% After Daiwa Boosts Stake And REGAL Nears Readout - Has The Bull Case Changed?

In recent months, Daiwa Securities very sharply increased its stake in SELLAS Life Sciences Group by 100,300 shares, while SELLAS reported that its Phase 3 REGAL trial in acute myeloid leukemia had reached 78 of the 80 events required for final analysis and held an estimated US$138.30 million in cash at the end of June. This combination of an imminent pivotal trial readout and a strengthened institutional presence highlights how clinical and balance-sheet milestones are converging for...

Investing.com20h agobearish
Pinterest falls 7% on weak third quarter revenue outlook

Investing.com -- Pinterest Inc (NYSE:PINS) reported second quarter results that exceeded Wall Street expectations, but shares tumbled 7% in after-hours trading Tuesday as the company’s third quarter revenue guidance disappointed investors.

CVS’s Turnaround Faces Its Next Test
Barrons.com21h agobearish
CVS’s Turnaround Faces Its Next Test

CVS Health reports earnings Wednesday, with analysts expecting another solid quarter and looking for potential guidance upside from its Aetna insurance and Caremark pharmacy-benefit businesses.

Chipotle stock plunges due to salmonella concerns: AlphaSpace check
Yahoo Finance Video21h agobearishVIDEO
Chipotle stock plunges due to salmonella concerns: AlphaSpace check

Yahoo Finance Senior Reporter Brooke DiPalma and Market Domination host Josh Lipton take a closer look at one of Tuesday's trending stories: Chipotle (CMG) pulling its jalapeños due to salmonella concerns. Watch the video above to learn more. Yahoo Finance's AlphaSpace is a premium investment platform that combines data, charting, news, analysis, and more to help retail investors understand markets.